EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID‐19 Infection Before or After Colorectal Cancer Diagnosis Is an Independent Predictor of Mortality and Treatment Delays Compared to Patients Who Never Tested Positive

Imran Qureshi iD, Steven Rella, Aasma Shaukat

Cancer Medicine · 2025

DOI: 10.1002/cam4.71411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Imran Qureshi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: COVID-19, Colorectal Neoplasms, Time-to-Treatment. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Given COVID‐19's emergence as a new entity and colorectal cancer's (CRC) rising incidence in certain populations, we conducted this retrospective cohort study to determine the link between COVID‐19 and the mortality of those with CRC and how socioeconomic factors influence it.

Methods

Using the National Cancer Database (NCDB), we used logistic regression to get the odds ratio (OR) for delayed treatment and Cox proportional hazards modeling for each stage to get the adjusted hazard ratios (HR) of mortality.

Results

COVID‐19 positivity was associated with higher mortality and delayed treatment. The association of race, ethnicity, insurance, urbanization, comorbidity burden, education levels, and income varied by when the patient tested positive relative to colorectal cancer diagnosis.

Conclusions

This implies that vaccinations may be a part of management and that CRC patients who develop COVID‐19 infection may warrant closer follow‐up during treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Colorectal NeoplasmsTime-to-TreatmentHumansMaleFemaleRetrospective StudiesMiddle AgedAgedSARS-CoV-2Socioeconomic FactorsProportional Hazards ModelsAged, 80 and overUnited StatesAdultRisk FactorsTreatment Delay

Stichwörter der Autor:innen

COVID‐19colorectal cancerhealthcare disparitiesvaccination

Autor:innen und Institutionen

  • Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Imran Qureshi

Zitieren

APA

Qureshi, I., Rella, S., & Shaukat, A. (2025). COVID‐19 Infection Before or After Colorectal Cancer Diagnosis Is an Independent Predictor of Mortality and Treatment Delays Compared to Patients Who Never Tested Positive. Cancer Medicine. https://doi.org/10.1002/cam4.71411

Vancouver

Qureshi I, Rella S, Shaukat A. COVID‐19 Infection Before or After Colorectal Cancer Diagnosis Is an Independent Predictor of Mortality and Treatment Delays Compared to Patients Who Never Tested Positive. Cancer Medicine. 2025. doi:10.1002/cam4.71411

BibTeX
@article{Qureshi2025,
  author = {Qureshi, Imran and Rella, Steven and Shaukat, Aasma},
  title = {COVID‐19 Infection Before or After Colorectal Cancer Diagnosis Is an Independent Predictor of Mortality and Treatment Delays Compared to Patients Who Never Tested Positive},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71411}
}
Kostenlos starten →